BIOPHARMASPEC - Company finances
|
EUR
|
2024
From: 2024-03-08
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | - | 119,704 |
| Profit before tax | -276,142 | -554,943 |
| Net profit | -276,142 | -554,943 |
| Equity | -275,142 | -830,085 |
| Liabilities | 594,800 | 1,161,672 |
| Non-current assets | 77,303 | 209,403 |
| Current assets | 242,355 | 114,500 |
| Total assets | 319,658 | 323,903 |
|
Taxes paid
|
||
| STI taxes | 8,411 | 20,393 |
| Social insurance contributions | 3,415 | 49,535 |
|
Financial indicators
|
||
| Revenue change y/y | - | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -86.4% | -171.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -463.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -463.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 19,153 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BIOPHARMASPEC - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-06-17 | 4397.96 |
| 2026-03-27 | 2026-03-27 | 4881.05 |
| 2026-03-17 | 2026-03-18 | 4881.05 |
| 2026-01-21 | 2026-02-02 | 3.53 |
| 2026-01-16 | 2026-01-20 | 6085.30 |
| 2025-11-18 | 2025-11-20 | 4522.46 |
| 2024-11-18 | 2024-11-18 | 1219.00 |
BIOPHARMASPEC - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.